nodes	percent_of_prediction	percent_of_DWPC	metapath
Ammonium lactate—Ichthyosis—Bleomycin—lymphatic system cancer	0.147	0.147	CcSEcCtD
Ammonium lactate—Ichthyosis acquired—Bleomycin—lymphatic system cancer	0.147	0.147	CcSEcCtD
Ammonium lactate—Localized exfoliation—Bleomycin—lymphatic system cancer	0.063	0.063	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Mechlorethamine—lymphatic system cancer	0.0601	0.0601	CcSEcCtD
Ammonium lactate—Petechiae—Mechlorethamine—lymphatic system cancer	0.0434	0.0434	CcSEcCtD
Ammonium lactate—Extravasation—Teniposide—lymphatic system cancer	0.0302	0.0302	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Bleomycin—lymphatic system cancer	0.0285	0.0285	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Carmustine—lymphatic system cancer	0.0249	0.0249	CcSEcCtD
Ammonium lactate—Phlebitis—Teniposide—lymphatic system cancer	0.0222	0.0222	CcSEcCtD
Ammonium lactate—Phlebitis—Fludarabine—lymphatic system cancer	0.0195	0.0195	CcSEcCtD
Ammonium lactate—Extravasation—Bleomycin—lymphatic system cancer	0.0195	0.0195	CcSEcCtD
Ammonium lactate—Extravasation—Carmustine—lymphatic system cancer	0.017	0.017	CcSEcCtD
Ammonium lactate—Petechiae—Mitoxantrone—lymphatic system cancer	0.0167	0.0167	CcSEcCtD
Ammonium lactate—Extravasation—Vincristine—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Ammonium lactate—Skin exfoliation—Bleomycin—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Ammonium lactate—Extravasation—Mitoxantrone—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Ammonium lactate—Phlebitis—Bleomycin—lymphatic system cancer	0.0143	0.0143	CcSEcCtD
Ammonium lactate—Skin exfoliation—Carmustine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Ammonium lactate—Infection—Mechlorethamine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Ammonium lactate—Phlebitis—Carmustine—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Ammonium lactate—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Ammonium lactate—Phlebitis—Mitoxantrone—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Methotrexate—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Ammonium lactate—Infection—Teniposide—lymphatic system cancer	0.00934	0.00934	CcSEcCtD
Ammonium lactate—Petechiae—Methotrexate—lymphatic system cancer	0.00835	0.00835	CcSEcCtD
Ammonium lactate—Infection—Fludarabine—lymphatic system cancer	0.00821	0.00821	CcSEcCtD
Ammonium lactate—Rash—Mechlorethamine—lymphatic system cancer	0.00804	0.00804	CcSEcCtD
Ammonium lactate—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00803	0.00803	CcSEcCtD
Ammonium lactate—Extravasation—Methotrexate—lymphatic system cancer	0.00787	0.00787	CcSEcCtD
Ammonium lactate—Body temperature increased—Teniposide—lymphatic system cancer	0.00743	0.00743	CcSEcCtD
Ammonium lactate—Erythema—Bleomycin—lymphatic system cancer	0.00742	0.00742	CcSEcCtD
Ammonium lactate—Pain—Fludarabine—lymphatic system cancer	0.00707	0.00707	CcSEcCtD
Ammonium lactate—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00655	0.00655	CcSEcCtD
Ammonium lactate—Body temperature increased—Fludarabine—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Ammonium lactate—Erythema—Carmustine—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Ammonium lactate—Erythema—Mitoxantrone—lymphatic system cancer	0.00602	0.00602	CcSEcCtD
Ammonium lactate—Infection—Bleomycin—lymphatic system cancer	0.00602	0.00602	CcSEcCtD
Ammonium lactate—Rash—Teniposide—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Ammonium lactate—Dermatitis—Teniposide—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Ammonium lactate—Infection—Carmustine—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Ammonium lactate—Rash—Fludarabine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Ammonium lactate—Dermatitis—Fludarabine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Ammonium lactate—Pain—Bleomycin—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Ammonium lactate—Infection—Vincristine—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Ammonium lactate—Infection—Mitoxantrone—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Ammonium lactate—Body temperature increased—Bleomycin—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Ammonium lactate—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Ammonium lactate—Pain—Carmustine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Ammonium lactate—Pain—Vincristine—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Ammonium lactate—Pain—Mitoxantrone—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Ammonium lactate—Body temperature increased—Carmustine—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Ammonium lactate—Body temperature increased—Vincristine—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Ammonium lactate—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Ammonium lactate—Rash—Bleomycin—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Ammonium lactate—Dermatitis—Bleomycin—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Ammonium lactate—Rash—Carmustine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Ammonium lactate—Dermatitis—Carmustine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Ammonium lactate—Rash—Vincristine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Ammonium lactate—Dermatitis—Vincristine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Ammonium lactate—Rash—Mitoxantrone—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Ammonium lactate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Ammonium lactate—Erythema—Methotrexate—lymphatic system cancer	0.003	0.003	CcSEcCtD
Ammonium lactate—Infection—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Ammonium lactate—Skin disorder—Methotrexate—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Ammonium lactate—Pain—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Ammonium lactate—Body temperature increased—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Ammonium lactate—Rash—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Ammonium lactate—Dermatitis—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
